raises in Biological Technology

TSH Testing Raises Awareness of Importance of Thyroid Health

SAINT JOHN, New Brunswick, Aug. 5 /PRNewswire/ -- A new effort to examine the link between nuclear reactors and thyroid disease near NYC was made at Croton on Hudson, during this year's Clearwater Festival. The festival is held just downstream from Indian Point, the oldest operating nucl...

NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State

NEW YORK, July 1 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ) announced today that it has raised additional gross funds of over $4 million from institutional and private investors. These funds, together with the $11 million private placement from three Asia-based investors announced...

Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals

UPPSALA, Sweden, June 29 /PRNewswire/ -- - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million)...

Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates

OSLO, Norway, June 26 /PRNewswire-FirstCall/ -- Clavis Pharma ASA (OSE: CLAVIS) today announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private placement of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK...

Americans United for Life: Obama's Disbanding Bioethics Council Raises Troubling Questions

WASHINGTON, June 19 /PRNewswire-USNewswire/ -- Americans United for Life (AUL) criticized President Obama's recent decision to disband the President's Council on Bioethics and replace it with a new bioethics commission having a mandate to offer "practical policy options." The President'...

Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million

Proteon also receives orphan drug designation for its lead product candidate, PRT-201 WALTHAM, Mass., May 28 /PRNewswire/ -- Proteon Therapeutics, Inc., announced today that it has completed a second closing of its Series B equity financing, securing an additional $12 million and increasing t...

Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance

BEIJING, May 8 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB, "Yongye" or the "Company"), a leading developer and distributor of plant and animal nutrient products in the People's Republic of China, today announced that it closed a private pl...

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

Company to Advance Ganaxolone Program for the Treatment of Epilepsy BRANFORD, Conn., April 10 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a developer of drugs to treat serious neurological and psychiatric disorders, today announced the close of a $20 million Series B financing. The funding...

BioVex Raises $40 Million in First Close of Series F Financing

WOBURN, Mass., March 30 /PRNewswire/ -- BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today it has raised $40 million in the first close of a series F private financing. The placement was led by Forbion C...

Moody's Raises Boston Scientific's Rating Outlook to Stable

NATICK, Mass., March 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that Moody's Investors Service has raised the Company's rating outlook to stable from negative. In addition, Moody's upgraded the Company's U.S. public bond rating to Ba1 from Ba2 and it...

GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners

SCHLIEREN, Switzerland, March 5 /PRNewswire/ -- - Proceeds to Facilitate Clinical Development of Lead Conjugate Vaccine GlycoVaxyn, a pioneer in the development of innovative conjugated vaccines, today announced the successful closing of a CHF25 million (ca. US$22 million, EUR17 ...

Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round

PALO ALTO, Calif., Feb. 24 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised $7.1 million in a Series A financing co-led by InterWest Partners and Vivo Ventures. The two firms were instrumental in the f...

NanoBio Corporation Raises $12 Million in Series B Financing

ANN ARBOR, Mich., Feb. 18 /PRNewswire/ -- NanoBio Corp., a biopharmaceutical company developing dermatological products, anti-infective treatments and intranasal vaccines, announced today that it has acquired $12 million in series B equity financing with Perseus LLC and other existing investor...

Divergence Raises $11.8 Million in Series C Financing

Biotechnology firm Divergence, Inc., a world leader in developing products for the control of parasites in agriculture and medicine, today announced that it has raised $11.8 million in a Series C financing round that will further its efforts to create solutions for one of the major causes of crop...

Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.

ST LOUIS, Feb. 11 /PRNewswire-FirstCall/ -- Sigma-Aldrich, a leading Life Science and High Technology company, reported that its fourth quarter 2008 diluted EPS grew by 6% to $0.68 from $0.64 in the same quarter of 2007. Reported sales of $510 million in the fourth quarter 2008 declined...

JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism

JMAR Technologies, Inc. (OTCBB: JMAR), San Diego, CA, a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced a media awareness initiative for JMAR's award-win...

Anacor Raises $50 Million in Equity Financing

PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it has raised $50 million through a preferred stock financing with participation from GlaxoSmithKline, Schering Corporation and existing investors including Rho Capital Partners, Venrock Associates, Care Capi...

MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile

ANN ARBOR, Mich., Nov. 21 /PRNewswire/ -- MichBio, the association for Michigan's biosciences industry, welcomed nearly 500 biosciences professionals and service providers to its fourth annual Expo on Tuesday and Wednesday of this week at the Rock Financial ShowPlace in Novi, MI. The MichBio Expo...

Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture

BURLINGAME, Calif., Oct. 21 /PRNewswire/ -- Sensorin, which is developing and commercializing a novel self-calibrating pH measurement platform for bioprocess applications, today announced the closing of its second round of equity funding. Use of proceeds from the financing includes product dev...

Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth

CLEVELAND, Ohio and TEL AVIV, Israel, October 15 /PRNewswire/ -- Simbionix USA Corporation is pleased to announce the completion of a Series C round of growth capital financing led by River Cities Capital Funds, along with incumbent investor Early Stage Partners and other existing shareholders...

Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65

LOS ANGELES, Oct. 13 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on leading Australian biotechnology company Arana Therapeutics, (ASX: AAH; AIM: AAHx) and raised its target price to AU$1.65. "In our opinion, Arana differentiates itself from many competitors in t...

Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation

Event Raises $4.6 Million in Four Years ST. CHARLES, Mo., Oct. 2 /PRNewswire-FirstCall/ -- Ameristar Casinos, Inc. (Nasdaq: ASCA ), announced today that the fourth annual Ameristar National Charity Golf Classic, hosted by the Ameristar Cares Foundation, the Company's philanthr...

China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income

-- Expects Revenue of $88 to $90 Million and Net Income of $27 to $28 Million HARBIN, China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceuti...

MacroGenics Raises $25M in Series D-2 Financing

Proceeds to be Used for Advancement of Cancer Stem Cells and Other Development Programs ROCKVILLE, Md., Sept. 25 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infe...

Yongye Biotechnology International Raises $9.4 Million in Private Placement

BEIJING, Sept. 10 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced that it closed...

Proteolix Raises $79 Million in Series C Financing

Funds to Support Clinical Development of Carfilzomib Paul Hastings Appointed to Board of Directors SOUTH SAN FRANCISCO, Calif., Sept. 8 /PRNewswire/ -- Proteolix, Inc., a leader in the discovery and development of novel therapeutics that target protein degradation pathway...

Bacon Eating Contest Raises Money for American Heart Association

SAN FRANCISCO, Aug. 26 /PRNewswire/ -- Nathan's Famous Hot Dog Eating contest may have Joey Chestnut, but the Brown & Toland Medical Group calls Beverly Del Rosario "champ." The senior human resources associate munched her way to a first unofficial competitive eating title earlier this month...

Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results

Company Posts Second Quarter EPS of $0.85 Per Diluted Share, An Increase of 31 Percent DEERFIELD, Ill., July 17 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX ) today posted strong financial results for the second quarter of 2008 and raised its full...

Pacific Biosciences Raises $100 Million to Fund Commercial Product Development

MENLO PARK, Calif., July 14 /PRNewswire/ -- Pacific Biosciences announced today that it has secured $100 million in a Series E private equity financing round. The proceeds will be used to fund the commercial development of the company's innovative single-molecule, real-time (SMRT(TM)) DNA sequ...

Alseres Pharmaceuticals, Inc. Raises $5 Million

HOPKINTON, Mass., June 30 /PRNewswire-FirstCall/ -- On June 25, 2008, Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE ), a biopharmaceuticals company engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system, entered a into Convertible...

BSP Raises $2.6 Million Dollars From Private Investors

TEL AVIV, Israel, June 17 /PRNewswire-FirstCall/ -- BSP Ltd., ( http://www.bsp.co.il/pressall.asp ) an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of Ischemic Heart Disease, announced that they successfully raised $2.6 million in a private fundi...

Merrimack Pharmaceuticals Raises $60 Million in Private Financing

Funds provide resources to advance Merrimack's robust pipeline of biologics targeting autoimmune disease and cancer CAMBRIDGE, Mass., June 10 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of novel treatments for a...

Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season

"Clear to Drive" Campaign Urges Allergy Sufferers to Check Medicine Labels for Drowsiness Warnings Before Getting Behind the Wheel KENILWORTH, N.J., May 6 /PRNewswire-FirstCall/ -- Summer is fast approaching, bringing sunshine, vacation days, and trips to the beach. But the warmer weathe...

New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor

SEATTLE, May 1 /PRNewswire/ -- Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results, especially if a major tumor suppressor gene -- p53 -- is already compromised, accor...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

- Company Posts Record Quarterly EPS of $0.58, 45% Above Prior Year, Based on Positive Operating Results and One-Time Legal Benefit - - Total Revenues Increase 21% to Establish Quarterly Record of $122.6 Million, Product Sales Rise 16% to All-Time High of $101.5 Million - - For 2008, ...

Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.

ST. LOUIS, April 22 /PRNewswire-FirstCall/ -- HIGHLIGHTS: 2008 Results (all percentage comparisons are to comparable periods in 2007): -- Q1 2008 Sales Set New Quarterly Record: Q1 2008 sales reached a new quarterly high of $569.6 million, an increase of 14.9%, with all ...

Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance

- Strong Sales Growth Across All Product Lines - Transcatheter Valves Propel Heart Valve Sales Growth - Special Items Reduce Net Income by $15 Million IRVINE, Calif., April 22 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW ), a world leade...

Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook

Company Continues to Advance Product Pipeline with Increased Investment in Research & Development DEERFIELD, Ill., April 17 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX ) today reported solid financial results for the first quarter of 2008, and raised ...

Stemline Therapeutics Raises $12.5 Million

Proceeds to advance oncology therapeutics targeting cancer stem cells NEW YORK, April 9, 2008 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company and a leading developer of oncology compounds directed to cancer stem cell targets, today announced that it has...

Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing

MONMOUTH JUNCTION, N.J., March 31 /PRNewswire/ -- Transave, Inc., a biopharmaceutical company focused on developing innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases today announced that it has raised an aggregate of $35 million pursuant to its recentl...